Next Eye Co., Ltd.

As of March 31, 2026, Next Eye Co., Ltd. carries a market capitalization of 21.82B, placing it among publicly traded companies globally. Its enterprise value stands at -1.82B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of March 31, 2026, Next Eye Co., Ltd. has 8.36M shares outstanding.

These figures are as of March 31, 2026. The price-to-sales ratio is 0.13, and the price-to-book ratio stands at 0.43.

As of March 31, 2026, Next Eye Co., Ltd. maintains a current ratio of 1.17, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 33.77, indicating elevated leverage, while an interest coverage ratio of -31.27 demonstrates limited ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Next Eye Co., Ltd. posted a negative return on equity (ROE) of -50.48, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -30.62, reflecting losses generated across the asset base. The company generates approximately 6.02B in revenue per employee across its workforce of 28.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 3.47 indicates how many times Next Eye Co., Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Next Eye Co., Ltd. recorded 435.01M in income tax expense. The company reported a pretax loss of -34.90B and -34.16B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, Next Eye Co., Ltd.'s stock has declined approximately 43.57% over the past 52 weeks. The 50-day moving average sits at 1,950.54, while the 200-day moving average is 2,334.67.

Over the twelve months ended March 31, 2026, Next Eye Co., Ltd. generated 168.45B in revenue and converted that into -34.16B in net income, yielding earnings per share of -4,272.57. EBITDA reached -28.25B, while operating income came in at -25.35B.

As of March 31, 2026, Next Eye Co., Ltd. holds 36.89B in cash and equivalents against 16.11B in total debt, resulting in a net debt position of -10.21B. Total book value stands at 50.55B, with working capital of 9.52B providing operational flexibility.

Next Eye Co., Ltd. produced -5.41B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -19.60M in capital expenditures, free cash flow totaled -5.43B - equivalent to -656.45 per share.

Over the twelve months ended March 31, 2026, Next Eye Co., Ltd. posted a gross margin of 82.23, reflecting its pricing power and cost economics. The operating margin of -15.05 and net profit margin of -20.28 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield is negative at -25.15: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield reaches 11.61, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Next Eye Co., Ltd. shareholders.

Next Eye Co., Ltd.'s most recent stock split took place on May 27, 2026 with a 10:1 split ratio.

As of March 31, 2026, Next Eye Co., Ltd. has an Altman Z-Score of 0.93, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.